Palantir insiders sold $1B in stock despite growth, signaling overvaluation concerns. Its high operating margins are ...

Palantir Technologies is an exciting company, but its stock is not a buy now. Investors should consider waiting for a far ...

The Cleveland Clinic use case is more than a headline win, it’s a real-world validation of Palantir’s enterprise AI thesis. By reducing ER wait times, reducing unused orthopedic OR time ...

This unique sales method features 5-day bootcamps that assist potential customers in applying Palantir’s AI products to address real-world use cases, helping transition ... using its proven platforms ...

Palantir serves both the public and private sectors. Palantir is well positioned to build a sizable AI business. Palantir’s government business can sustain its growth momentum in the coming years.

Well, apparently the market has been pricing Palantir ... Gotham, which is their operating system for intelligence and defense, designed to integrate all the data into one platform and use ...

Ideally, that's our end state for all of this.” In a release last year, TGH reported Palantir use cases increased from one to more than 12 applications across the hospital. Goldstein said he’s ...

Palantir (NASDAQ: PLTR) has been one of the hottest stocks in town, more than tripling its share price over the last 12 months. Its strategic position as a leader in the artificial intelligence ...

It makes Palantir's software flexible. Some of Palantir's use cases include optimizing supply chains, managing hospitals, detecting financial fraud, and aiding military intelligence and mission ...